A citation-based method for searching scientific literature

N Jalandhara, R Arora, V Batuman. Clin Pharmacol Ther 2011
Times Cited: 22







List of co-cited articles
91 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Eric J Werner, Ankona Datta, Christoph J Jocher, Kenneth N Raymond. Angew Chem Int Ed Engl 2008
254
18

Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
Javier Perez-Rodriguez, Shenghan Lai, Benjamin D Ehst, Derek M Fine, David A Bluemke. Radiology 2009
150
18

Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.
Jessica Wahsner, Eric M Gale, Aurora Rodríguez-Rodríguez, Peter Caravan. Chem Rev 2019
431
18

Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.
Arne Skjold, Brage H Amundsen, Rune Wiseth, Asbjørn Støylen, Olav Haraldseth, Henrik B W Larsson, Per Jynge. J Magn Reson Imaging 2007
34
13

Safety and optimum concentration of a manganese chloride-based oral MR contrast agent.
M E Bernardino, J C Weinreb, D G Mitchell, W C Small, M Morris. J Magn Reson Imaging 1994
28
13

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients.
S E Cowper, H S Robin, S M Steinberg, L D Su, S Gupta, P E LeBoit. Lancet 2000
632
13

Challenges for molecular magnetic resonance imaging.
Enzo Terreno, Daniela Delli Castelli, Alessandra Viale, Silvio Aime. Chem Rev 2010
408
13

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.
Henrik S Thomsen, Sameh K Morcos, Torsten Almén, Marie-France Bellin, Michele Bertolotto, Georg Bongartz, Olivier Clement, Peter Leander, Gertraud Heinz-Peer, Peter Reimer,[...]. Eur Radiol 2013
272
13

Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
Sophie Laurent, Delphine Forge, Marc Port, Alain Roch, Caroline Robic, Luce Vander Elst, Robert N Muller. Chem Rev 2008
13

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
Robert J McDonald, Jennifer S McDonald, David F Kallmes, Mark E Jentoft, David L Murray, Kent R Thielen, Eric E Williamson, Laurence J Eckel. Radiology 2015
854
13


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
13

Organelle-targeted photothermal agents for cancer therapy.
Eunbin Hwang, Hyo Sung Jung. Chem Commun (Camb) 2021
5
60

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
Jacek Zielonka, Joy Joseph, Adam Sikora, Micael Hardy, Olivier Ouari, Jeannette Vasquez-Vivar, Gang Cheng, Marcos Lopez, Balaraman Kalyanaraman. Chem Rev 2017
543
13

Multifunctional nanoparticles for multimodal imaging and theragnosis.
Dong-Eun Lee, Heebeom Koo, In-Cheol Sun, Ju Hee Ryu, Kwangmeyung Kim, Ick Chan Kwon. Chem Soc Rev 2012
758
13

Boosting Cancer Therapy with Organelle-Targeted Nanomaterials.
Peng Gao, Wei Pan, Na Li, Bo Tang. ACS Appl Mater Interfaces 2019
92
13

Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.
Xianglei Fu, Yanbin Shi, Tongtong Qi, Shengnan Qiu, Yi Huang, Xiaogang Zhao, Qifeng Sun, Guimei Lin. Signal Transduct Target Ther 2020
27
13

Hetero-Trifunctional Malonate-Based Nanotheranostic System for Targeted Breast Cancer Therapy.
Tapan Kumar Dash, Diptendu Patra, Parvathy Venu, Biswajit Das, Rangeet Bhattacharyya, Raja Shunmugam. ACS Appl Bio Mater 2021
3
100

Mitochondrially targeted anti-cancer agents.
Lucia Biasutto, Lan-Feng Dong, Mario Zoratti, Jiri Neuzil. Mitochondrion 2010
94
13

Drug delivery to mitochondria: the key to mitochondrial medicine.
M P Murphy, R A Smith. Adv Drug Deliv Rev 2000
316
13


Mitochondria as a pharmacological target.
Adam Szewczyk, Lech Wojtczak. Pharmacol Rev 2002
369
13

Cancer nanomedicine: progress, challenges and opportunities.
Jinjun Shi, Philip W Kantoff, Richard Wooster, Omid C Farokhzad. Nat Rev Cancer 2017
13

Iron(III) Coordinated Polymeric Nanomaterial: A Next-Generation Theranostic Agent for High-Resolution T1-Weighted Magnetic Resonance Imaging and Anticancer Drug Delivery.
Diptendu Patra, Saikat Mukherjee, Ipsita Chakraborty, Tapan K Dash, Shantibhusan Senapati, Rangeet Bhattacharyya, Raja Shunmugam. ACS Biomater Sci Eng 2018
8
37

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly, Omid C Farokhzad. Adv Drug Deliv Rev 2014
13

Mitochondrial dysfunction in cancer.
Josephine S Modica-Napolitano, Keshav K Singh. Mitochondrion 2004
228
13

Mitochondria in cancer cells: what is so special about them?
Vladimir Gogvadze, Sten Orrenius, Boris Zhivotovsky. Trends Cell Biol 2008
442
13

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
13

MRI for breast cancer screening, diagnosis, and treatment.
Monica Morrow, Janet Waters, Elizabeth Morris. Lancet 2011
192
13

Combinatorial drug therapy for cancer in the post-genomic era.
Bissan Al-Lazikani, Udai Banerji, Paul Workman. Nat Biotechnol 2012
574
13


Mitochondrial form and function.
Jonathan R Friedman, Jodi Nunnari. Nature 2014
836
13

Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy.
Xiaowei Wang, Yuhan Qiu, Mengyan Wang, Conghui Zhang, Tianshu Zhang, Huimin Zhou, Wenxia Zhao, Wuli Zhao, Guimin Xia, Rongguang Shao. Int J Nanomedicine 2020
12
25

Chemistry. Nanomaterials for drug delivery.
Jeffrey A Hubbell, Ashutosh Chilkoti. Science 2012
268
13

Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.
Gantumur Battogtokh, Yeon Su Choi, Dong Seop Kang, Sang Jun Park, Min Suk Shim, Kang Moo Huh, Yong-Yeon Cho, Joo Young Lee, Hye Suk Lee, Han Chang Kang. Acta Pharm Sin B 2018
100
13

Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.
Piero Stratta, Caterina Canavese, Marco Quaglia, Roberta Fenoglio. Rheumatology (Oxford) 2010
5
40

Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Hyon Bin Na, Jung Hee Lee, Kwangjin An, Yong Il Park, Mihyun Park, In Su Lee, Do-Hyun Nam, Sung Tae Kim, Seung-Hoon Kim, Sang-Wook Kim,[...]. Angew Chem Int Ed Engl 2007
330
9

Nanomedicine strategies for molecular targets with MRI and optical imaging.
Dipanjan Pan, Shelton D Caruthers, Junjie Chen, Patrick M Winter, Angana SenPan, Anne H Schmieder, Samuel A Wickline, Gregory M Lanza. Future Med Chem 2010
52
9


Gadolinium and systemic fibrosis: guilt by association.
Jonathan Kay, László Czirják. Ann Rheum Dis 2010
14
14

Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies.
Annabelle Bertin, Jérôme Steibel, Anne-Isabelle Michou-Gallani, Jean-Louis Gallani, Delphine Felder-Flesch. Bioconjug Chem 2009
43
9

MRI contrast agents: current status and future perspectives.
Gustav J Strijkers, Willem J M Mulder, Geralda A F van Tilborg, Klaas Nicolay. Anticancer Agents Med Chem 2007
134
9

Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells.
Taeho Kim, Eric Momin, Jonghoon Choi, Kristy Yuan, Hasan Zaidi, Jaeyun Kim, Mihyun Park, Nohyun Lee, Michael T McMahon, Alfredo Quinones-Hinojosa,[...]. J Am Chem Soc 2011
285
9

Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling.
J A Chalela, D C Alsop, J B Gonzalez-Atavales, J A Maldjian, S E Kasner, J A Detre. Stroke 2000
380
9

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.
Gregory W Albers, Vincent N Thijs, Lawrence Wechsler, Stephanie Kemp, Gottfried Schlaug, Elaine Skalabrin, Roland Bammer, Wataru Kakuda, Maarten G Lansberg, Ashfaq Shuaib,[...]. Ann Neurol 2006
898
9

Acute stroke imaging research roadmap.
Max Wintermark, Gregory W Albers, Andrei V Alexandrov, Jeffry R Alger, Roland Bammer, Jean-Claude Baron, Stephen Davis, Bart M Demaerschalk, Colin P Derdeyn, Geoffrey A Donnan,[...]. Stroke 2008
168
9


Transfer insensitive labeling technique (TILT): application to multislice functional perfusion imaging.
X Golay, M Stuber, K P Pruessmann, D Meier, P Boesiger. J Magn Reson Imaging 1999
75
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.